Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

Townsend, W; Hiddemann, W; Buske, C; Cartron, G; Cunningham, D; Dyer, MJS; Gribben, JG; Phillips, EH; Dreyling, M; Seymour, JF; Grigg, A; Trotman, J; Lin, TY; Hong, XN; Kingbiel, D; Nielsen, TG; Knapp, A; Herold, M; Marcus, R

Townsend, W (通讯作者),Univ Coll Hosp London, Canc Res UK, London, England.;Townsend, W (通讯作者),Univ Coll Hosp London, UCL Canc Trials Ctr, London, England.

HEMASPHERE, 2023; 7 (7):

Abstract

The phase III GALLIUM trial assessed the safety and efficacy of obinutuzumab-based versus rituximab-based immunochemotherapy in patients with previous......

Full Text Link